Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

589 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial.
Johnsson A, Hagman H, Frödin JE, Berglund A, Keldsen N, Fernebro E, Sundberg J, De Pont Christensen R, Garm Spindler KL, Bergström D, Jakobsen A. Johnsson A, et al. Among authors: berglund a. Ann Oncol. 2013 Sep;24(9):2335-41. doi: 10.1093/annonc/mdt236. Epub 2013 Jun 19. Ann Oncol. 2013. PMID: 23788755 Free article. Clinical Trial.
Bolus injection (2-4 min) versus short-term (10-20 min) infusion of 5-fluorouracil in patients with advanced colorectal cancer: a prospective randomised trial. Nordic Gastrointestinal Tumour Adjuvant Therapy Group.
Glimelius B, Jakobsen A, Graf W, Berglund A, Gadeberg C, Hansen P, Kjaer M, Brunsgaard N, Sandberg E, Lindberg B, Sellström H, Lorentz T, Påhlman L, Gustavsson B. Glimelius B, et al. Among authors: berglund a. Eur J Cancer. 1998 Apr;34(5):674-8. doi: 10.1016/s0959-8049(97)10055-7. Eur J Cancer. 1998. PMID: 9713273 Clinical Trial.
Dose-effect relationship of bolus 5-fluorouracil in the treatment of advanced colorectal cancer.
Jakobsen A, Berglund A, Glimelius B, Frödin JE, Hansen F, Kjaer M, Madsen EL, Sandberg E, Poulsen JP, Carlsson G, Gustavsson B; Nordic Gastrointestinal Tumour Therapy Group, Norway, Sweden and Denmark. Jakobsen A, et al. Among authors: berglund a. Acta Oncol. 2002;41(6):525-31. doi: 10.1080/02841860214959. Acta Oncol. 2002. PMID: 12546525 Clinical Trial.
A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer.
Glimelius B, Sørbye H, Balteskard L, Byström P, Pfeiffer P, Tveit K, Heikkilä R, Keldsen N, Albertsson M, Starkhammar H, Garmo H, Berglund A. Glimelius B, et al. Among authors: berglund a. Ann Oncol. 2008 May;19(5):909-14. doi: 10.1093/annonc/mdm588. Epub 2008 Jan 21. Ann Oncol. 2008. PMID: 18209013 Free article. Clinical Trial.
Chronomodulated capecitabine in combination with short-time oxaliplatin: a Nordic phase II study of second-line therapy in patients with metastatic colorectal cancer after failure to irinotecan and 5-flourouracil.
Qvortrup C, Yilmaz M, Ogreid D, Berglund A, Balteskard L, Ploen J, Fokstuen T, Starkhammar H, Sørbye H, Tveit K, Pfeiffer P. Qvortrup C, et al. Among authors: berglund a. Ann Oncol. 2008 Jun;19(6):1154-9. doi: 10.1093/annonc/mdn002. Epub 2008 Feb 14. Ann Oncol. 2008. PMID: 18281265 Free article. Clinical Trial.
Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer.
Byström P, Berglund A, Garske U, Jacobsson H, Sundin A, Nygren P, Frödin JE, Glimelius B. Byström P, et al. Among authors: berglund a. Ann Oncol. 2009 Jun;20(6):1057-61. doi: 10.1093/annonc/mdn744. Epub 2009 Jan 22. Ann Oncol. 2009. PMID: 19164458 Free article. Clinical Trial.
589 results